412
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Modeling of the growth hormone secretagogue receptor antagonistic activity using chemometric tools

, , , &
Pages 1024-1033 | Received 12 Jul 2008, Accepted 26 Oct 2008, Published online: 23 Jun 2009

References

  • Klein S, Romijn JP. Chapter 33-Obesity. In: Williams Textbook of Endocrinology. 10th ed.: Larsen PR, Kronenberg HM, Melmed S, Polonsky KS (Eds.), WB Saunders Co., St. Louis: MO; 2003. p 1619–1635.
  • Kojima M, Hosoda H, Date Y, Nakazato H, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999;402:656–660.
  • Banks WA, Tschöp M, Robinson SM, Heiman ML. Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure. J Pharmacol Exp Ther. 2002;302:822–827.
  • Murikami N, Hayashida T, Kuroiwa T, Nakahara K, Ida T, Mondal MS, M. Nakazato M, Kojima M, Kangawa K. Role for central ghrelin in food intake and secretion profile of stomach ghrelin in rats. J Endocrinol 2002;174:283–288.
  • Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG, Dhillo WS, Ghatei MA, Bloom SR. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 2001;86:5992–5995.
  • Wren AM, Small CJ, Abbott CR, Dhillo WS, Seal LJ, Cohen MA, Batterham RL, Taheri S, Stanley SA, Ghatei MA, Bloom SR. Ghrelin causes hyperphagia and obesity in rats. Diabetes 2001;50:2540–2547.
  • Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S. A role for ghrelin feeding in the central regulation of feeding. Nature 2001;409:194–198.
  • Bagnasco M, Tulipano G, Melis MR, Argiolas A, Cocchi D, Muller EE. Endogenous ghrelin is an orexigenic peptide acting in the arcuate nucleus in response to fasting. Regul Pept 2003;111:161–167.
  • Asakawa A, Inui A, Kaga T, Katsuura G, Fujimiya M, Fujino MA, Kasuga M. Antagonism of ghrelin receptor reduces food intake and body weight gain in mice. Gut 2003;52:947–952.
  • Sun Y, Wang P, Zheng H, Smith RG. Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagouge receptor. Proc Natl Acad Sci USA 2004;101:4679–4684.
  • Shuto Y, Shibasaki T, Otagiri A, Kuriyama H, Ohata H, Tamura H, Kamegai J, Sugihara H, Oikawa S. Hypothalamic growth hormone secretagouge receptor regulates growth hormone secretion. J Clin Invest 2002;109:1429–1436.
  • Liu B, Liu G, Xin Z, Serby M, Zhao H, Schaefer V, Falls D, Kaszubska W, Collins C, Sham H. Novel isoxazole carboxamides as growth hormone secretagouge receptor antagonists. Bioorg Med Chem Lett 2004;14:5223–5226.
  • Xin Z, Zhao H, Serby M, Liu B, Schaefer V, Falls D, Kaszubska W, Collins C, Sham H, Liu G. Synthesis and structure-activity relationships of isoxazole carboxamides as growth hormone secretagouge receptor antagonists. Bioorg Med Chem Lett 2005;15:1201–1204.
  • Zhao H, Xin Z, Liu G, Schaefer V, Falls D, Kaszubska W, Collins C, Sham H. Discovery of tetralin carboxamide growth hormone secretagouge receptor antagonists via scaffold manipulation. J Med Chem 2004;47:6655–6657.
  • Zhao H, Xin Z, Patel JR, Nelson LTJ, Liu B, Szczepankiewicz BG, Schaefer V, Falls D, Kaszubska W, Collins C, Sham H, Liu G. Structure-activity relationships on tetralin carboxamide growth hormone secretagouge receptor antagonists. Bioorg Med Chem Lett 2005;15:1825–1828.
  • Serby MD, Zhao H, Szczepankiewicz BG, Kosogof C, Xin Z, Liu B, Liu M, Nelson LTJ, Kaszubska W, Falls HD, Schaefer V, Bush EN, Shapiro R, Droz BA, Knourek-Segel VE, Fay TA, Brune ME, Beno DWA, Turner TM, Collins CA, Jacobson PB, Sham HL, Liu G. 2,4-Diaminopyrimidine derivatives as potent growth hormone secretagouge receptor antagonists. J Med Chem 2006;49:2568–2578.
  • Basak SC, Harriss DK, Magnuson VR. POLLY, University of Minnesota, Duluth, MN, 1988.
  • Molconn-Z, ver. 2.07, eduSoft Lc, a Virginia Corporation, Ashland, VA 23005 USA. www.edusoft-lc.com.
  • (a) Katritzky AR, Lobnov V, Karelson M. CODESSA (Comprehensive descriptors for structural and statistical analysis), University of Florida, Gainesville, FL, 1994. (b) Katritzky AR, Perumal S, Petrukhin R, Kleinpeter E. CODESSA-based theoretical QSPR model for hydantoin HPLC-RT lipophilicities. J Chem Inf Comput Sci 2001;41:569–574.
  • DRAGON software version 3.0-2003. By Todeschini R, Consonni V, Mauri A, Pavan M. Milano, Italy. http//disat.unimib.it/chm/Dragon.htm.
  • Gonzalez MP, Helguera AM. TOPS-MODE verces DRAGON descriptors to predict permeability coefficients through low-density polymer. J Comput-Aided Mol Des 2003;17:665–672.
  • Prabhakar YS. A combinatorial approach to the variable selection in multiple linear regression: Analysis of Selwood et al data set – A case study. QSAR Comb Sci 2003;22: 583–595.
  • Gupta MK, Prabhakar YS. Topological descriptors in modeling the antimalarial activity of 4-(3’,5’-disubstituted aniline)quinolines. J Chem Inf Model. 2006;46;93–102.
  • Prabhakar YS, Solomon VR, Rawal RK, Gupta MK, Katti SB. CP-MLR/PLS directed structure-activity modeling of the HIV-1 RT inhibitory activity of 2,3-diaryl-1,3-thiazolidin-4-ones. QSAR Comb Sci 2004;23:234–244.
  • Prabhakar YS. A combinatorial protocol in multiple linear regression to model gas chromatographic response factor of organophosphonate esters. Internet Electron J Mol Des 2004;3:150–162. http://www.biochempress.com.
  • Gupta MK, Sagar R, Shaw AK, Prabhakar YS. CP-MLR directed QSAR studies on the antimycobacterial activity of functionalized alkenols-topological descriptors in modeling the activity. Bioorg Med Chem 2005;13:343–351.
  • Saquib M, Gupta MK, Sagar R, Prabhakar YS, Shaw AK, Kumar R, Maulik PR, Gaikwad, AN, Sinha S, Srivastava AK, Chaturvedi V, Srivastava R, Srivastava BS. C-3 alkyl/arylalkyl-2,3-dideoxy hex-2-enopyranosides as antitubercular agents: Synthesis, biological evaluation and QSAR study. J Med Chem 2007;50:2942–2950.
  • Fujita T, Ban T. Structure-activity relation. 3. Structure-activity study of phenethylamines as substrates of biosynthetic enzymes of sympathetic transmitters. J Med Chem 1971;14:148–152.
  • Hansch C, Fujita T. p-σ-π analysis. A method for the correlation of biological activity and chemical structure. J Am Chem Soc 1964;86:1616–1626.
  • Hansch C. Quantitative approach to biochemical structure-activity relationships. Acc Chem Res 1969;2:232–239.
  • Hansch C. In: Drug Design, Vol. I, Ariens EJ (Ed.) New York, N Y-Academic Press, 1971. p 271.
  • Hansch C, Leo A. Substituents constants for correlation analysis in chemistry and biology, New York, John Wiley, 1979.
  • So SS, Karplus M. Three-dimensional quantitative structure-activity relationship from molecular similarity matrices and genetic neural networks. 2. Applications. J Med Chem 1997;40:4347–4359.
  • Wold S, Eriksson L. Statistical validation of QSAR results. In: Chemometrics methods in molecular design, H. Van de Waterbeemed (Ed.), Wiley-VCH, Weinheim, 1995.
  • Efron B. Estimating the error rate of a prediction rule: Some improvement on cross-validation. J Am Stat Assoc 1983;78:316–331.
  • Efroymson MA. Multiple regression analysis. In: Mathematical methods for digital computers, Ralston A, Wilf HS (Eds.), Wiley-NewYork, 1960.
  • SYSTAT, Version 7.0 SPSS Inc., 444 North Michigan Avenue, Chicago, IL, 60611.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.